# acamprosate calcium

NDC: 70771-1057
Generic name: acamprosate calcium
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20170601

FDA application: ANDA205995

## Active ingredients

- ACAMPROSATE CALCIUM: 333 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1057"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1057
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c729939-d2d2-4e61-acbc-4f1646dc38c1